WHO essential medicines for reproductive health
- PMID: 31908878
- PMCID: PMC6936467
- DOI: 10.1136/bmjgh-2019-002150
WHO essential medicines for reproductive health
Keywords: abortion; essential medicines; health systems; postpartum hemorrhage; reproductive health.
Conflict of interest statement
Competing interests: None declared.
References
-
- WHO 22nd Expert Committee on the Selection and Use of Essential Medicines - Application for Mifepristone-Misoprostol, 2018.
-
- WHO WHO Recommendations: Uterotonics for the prevention of postpartum haemorrhage. World Health Organization, 2018. - PubMed
-
- WHO/PQT, Oxytocin injection Clarification of stability data and storage statement requirements. 31 Guidance document, 2018.
-
- WHO WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. World Health Organization, 2017. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources